Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
1,950,079
-
Shares change
-
-40,165
-
Total reported value, excl. options
-
$3,422,000
-
Value change
-
-$82,244
-
Number of buys
-
2
-
Number of sells
-
2
-
Price
-
$1.83
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2020
As of 30 Jun 2020 Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) had 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,950,079 shares of stock of the company.
Largest 5 holders included Knoll Capital Management, LP, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., WEDBUSH SECURITIES INC, and UBS Group AG.
This table shows 5 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.